CompletedNot applicableNCT02538016

TCUPS- Tolvaptan Use in Cystinuria and Urolithiasis: A Pilot Study

Studying Cystinuria

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Caleb Nelson
Principal Investigator: Caleb Nelson, MD, MPH, M.D
Boston Children's Hospital
Intervention: Tolvaptan(drug)
Enrollment: 4 enrolled
Eligibility: 12-29 years · All sexes
Timeline: 2016 – 2018

Study locations (1)

Boston Children's Hospital, Boston, Massachusetts, United States

Collaborators

Otsuka America Pharmaceutical

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02538016 on ClinicalTrials.gov

Other trials for Cystinuria

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGNANCT00169806
Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
Indiana Kidney Stone Institute

See all trials for Cystinuria →

← Back to all trials